StockData
PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc. (PMVP) stock

PMVPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.22+0.03 (+2.52%)

Close on Nov 17, 2026Market cap $65.22MP/E –Yield –

PMV Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

PMV Pharmaceuticals's price to book ratio was 0.9× on Nov 11, 2026, against 0.6× a year earlier. Over the last 5 years it ranged from 0.3× to 3.2×, with a median of 0.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×+0.4
2025Dec 31, 20250.5×+0.2
2024Dec 31, 20240.4×−0.3
2023Dec 29, 20230.7×−0.9
2022Dec 30, 20221.5×−1.7
2021Dec 31, 20213.2×−4.2
2020Dec 31, 20207.5×–

More PMV Pharmaceuticals figures

See a number that looks wrong?